Navigating Your Diagnosis: Huntington Disease-Like 2 (HDL2)
At a Glance
Huntington disease-like 2 (HDL2) is a rare inherited disorder caused by a JPH3 gene expansion. It can resemble Huntington disease and progressively affect movement, thinking, mood, and behavior; diagnosis helps guide supportive, multidisciplinary care and genetic counseling.
Receiving a diagnosis of Huntington disease-like 2 (HDL2) often marks the end of a long and exhausting search for answers. For many families, this journey—sometimes called a diagnostic odyssey—begins with the suspicion of Huntington’s Disease (HD), only to be followed by the confusion of a “negative” genetic test [1][2]. Finding out that you have HDL2 provides a name for your experience, but it also brings a new set of questions about a condition that is exceptionally rare and deeply personal.
Validating Your Journey
It is common to feel a complex mix of emotions when you finally receive an HDL2 diagnosis. You may feel a sense of validation that your symptoms are real and have a biological cause, but this is often coupled with the weight of knowing the condition is progressive [3].
Because HDL2 is a phenocopy of Huntington’s Disease—meaning it can closely resemble HD—many patients spend years being told they “might” have HD, only to be left in a diagnostic limbo when the standard HD test comes back clear [2]. Diagnosis can be delayed because the condition is rare and resembles HD [1]. This delay can lead to feelings of isolation and uncertainty. Acknowledge that the emotional toll of this wait is significant; you have been navigating a difficult path with very few guideposts.
Understanding HDL2
HDL2 is a rare, genetic neurological disorder that can cause progressive changes in movement, thinking, and mood [4]. It is caused by an expansion in the JPH3 gene [2].
- Why it is called an “HD-like condition”: The symptoms—such as chorea (involuntary, dance-like movements), dystonia (muscle stiffness), and cognitive changes—overlap so closely with HD that doctors usually cannot tell them apart without a genetic test [4][2].
- A Rare Connection: HDL2 is much rarer than HD. While exact global numbers are hard to pin down because the disease is often underdiagnosed, it is strongly associated with individuals of African ancestry [1][5].
- The Founder Effect: Researchers have reported a shared founder haplotype of African origin for the mutation [1][6]. Over centuries, this genetic marker was passed down, which is why it is almost exclusively seen in people of African or Afro-descendant heritage today [7][6]. However, testing should be guided by phenotype and specialist assessment rather than ancestry alone.
The Emotional Landscape
Living with HDL2 involves managing more than just physical symptoms. The neuropsychiatric symptoms—those affecting mood and behavior—can be some of the most challenging aspects of the condition [8].
- Mood Changes: Depression, anxiety, and apathy (a loss of motivation or interest) are frequently reported by patients and families [8][9].
- Cognitive Shifts: You may notice changes in how you process information or make decisions. These are not a reflection of your character, but a direct result of how the condition affects the brain [3][8].
- Grief and Family Planning: It is natural to grieve the life you lived before the diagnosis. Because the disease is autosomal dominant, there is a 50% chance of passing the genetic expansion to each child [3][1]. This risk applies independently to each pregnancy. Genetic counseling is highly recommended to discuss predictive testing (which is always voluntary) and reproductive options privately.
Moving Forward: You Are Not Alone
While HDL2 is a serious and progressive condition, having a correct diagnosis is the first step toward better management. Because the condition is so similar to HD, you can benefit from the decades of research and support systems already in place for Huntington’s families [3][10].
Management today focuses on “treating the person, not just the disease.” This involves a multidisciplinary care team—a group of specialists working together to support your quality of life:
- Neurologists to help manage movement symptoms like chorea [4].
- Psychiatrists or Counselors to address mood changes and provide emotional support for the whole family [9][10].
- Physical and Occupational Therapists to help maintain independence and mobility for as long as possible [3].
- Genetic Counselors to help you and your relatives understand what the JPH3 expansion means for your children and siblings [3][1].
Though the road ahead is challenging, the medical community’s understanding of HDL2 is growing. By connecting with specialized clinics and rare-disease communities, you can find the resources and advocacy needed to navigate this journey with dignity.
Common questions in this guide
How is Huntington disease-like 2 diagnosed?
What symptoms can HDL2 cause?
Is HDL2 inherited, and what does it mean for my children?
How is HDL2 managed?
How is HDL2 different from Huntington disease?
Is HDL2 more common in people of African ancestry?
What support can help after an HDL2 diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was my genetic test for JPH3 definitive, and what was the specific repeat count?
- 2.Because HDL2 is so rare, how much experience does this clinic have in treating it or other 'Huntington-like' conditions?
- 3.Since there isn't a specific 'HDL2 protocol,' which parts of the Huntington's Disease (HD) care model will we be using for my treatment?
- 4.Can you refer me to a genetic counselor who understands the specific implications of the JPH3 expansion for my children and siblings?
- 5.What symptoms should we be monitoring most closely right now—movement, mood, or cognitive changes?
- 6.Are there any clinical trials or registries specifically for HDL2 or rare choreas that I should know about?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
Krause A, Mitchell C, Essop F, et al.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2015; (168(7)):573-85 doi:10.1002/ajmg.b.32332.
PMID: 26079385 - 2
Huntington's disease-like 2 patients' profile in a Brazilian cohort.
Boone DL, Tumas V, Vilela G, et al.
Parkinsonism & related disorders 2025; (139()):108023 doi:10.1016/j.parkreldis.2025.108023.
PMID: 40914005 - 3
Current knowledge of Huntington's disease-like 2 genetic testing, clinical presentation, and patient experiences: A systematic review.
Hoffmann K, White S, Sexton A
Journal of Huntington's disease 2026; (15(3)):293-316 doi:10.1177/18796397251411109.
PMID: 41564273 - 4
Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.
Anderson DG, Ferreira-Correia A, Rodrigues FB, et al.
Movement disorders clinical practice 2019; (6(4)):302-311 doi:10.1002/mdc3.12742.
PMID: 31061838 - 5
Huntington disease-like 2: insight into neurodegeneration from an African disease.
Krause A, Anderson DG, Ferreira-Correia A, et al.
Nature reviews. Neurology 2024; (20(1)):36-49 doi:10.1038/s41582-023-00906-y.
PMID: 38114648 - 6
Spinocerebellar ataxia type 10 and Huntington disease-like 2 in Venezuela: Further evidence of two different ancestral founder effects.
Paradisi I, Arias S, Ikonomu V
Annals of human genetics 2024; (88(6)):445-454 doi:10.1111/ahg.12576.
PMID: 39212267 - 7
West-Central African Ancestry of the Repeat-Expansion Founder Mutation on the JPH3 Gene in Mexican Patients With Huntington's Disease-Like 2.
Ramírez-García MÁ, Yescas-Gómez P, Monroy-González JCM, et al.
Archives of medical research 2025; (56(5)):103208 doi:10.1016/j.arcmed.2025.103208.
PMID: 40187026 - 8
A Systematic Review of the Huntington Disease-Like 2 Phenotype.
Anderson DG, Walker RH, Connor M, et al.
Journal of Huntington's disease 2017; (6(1)):37-46 doi:10.3233/JHD-160232.
PMID: 28339400 - 9
The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease.
Ferreira-Correia A, Krause A, Anderson DG
Journal of Huntington's disease 2020; (9(4)):325-334 doi:10.3233/JHD-200422.
PMID: 33044188 - 10
Presentation and care of a family with Huntington disease in a resource-limited community.
Charles J, Lessey L, Rooney J, et al.
Journal of clinical movement disorders 2017; (4()):4 doi:10.1186/s40734-017-0050-6.
PMID: 28413688
This page about Huntington disease-like 2 is for informational purposes only and does not constitute medical advice. A neurologist, genetic counselor, and other qualified clinicians can help interpret your test results and plan care.
Get notified when new evidence is published on Huntington disease-like 2.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.